WIXOM, MI, Oct 27 (MARKET WIRE) — Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceuticalcompany offering innovative products and services targeting end-stagerenal disease (ESRD), chronic kidney disease (CKD), and iron deficiencyanemia, announced today that it has unveiled a new corporate identityconsisting of a new logo, Company name and website.”Our new name, Rockwell Medical, more accurately reflects the strategicdirection and corporate identity of our Company,” stated Robert L.Chioini, Chairman and CEO. “We are pleasedthat we were able to increase the number of grants in the “Housing forEveryone” competition this year and help thousands of people from Maine toFlorida continue to have a place to call their home.”The 2009 “Housing for Everyone” competition focused on supporting housingstabilization efforts for fiscally-responsible affordable housingorganizations. It also maintains sevenlimited service offices in adult life care communities. Eastern Time.The conference call can be accessed by dialing877-397-0298, or through the James River Coal Company website at http:// callers, please dial719-325-4834.A replay of the conference call will be available on theCompany’s website and also by telephone, at 888-203-1112 for domestic callers.
Harbor Forward-Looking Statements To the extent that statements in this press release are not strictly historical,including statements as to revenue projections, business strategy, outlook,objectives, future milestones, plans, intentions, goals, future financialconditions, future collaboration agreements, the success of the Company’sdevelopment, events conditioned on stockholder or other approval, or otherwiseas to future events, such statements are forward-looking, and are made pursuantto the safe harbor provisions of the Private Securities Litigation Reform Act of1995. Given that our fourth quarter isseasonally strong, we are in a comfortable position to achieve our target ofrevenue growth in 2009 over that of 2008. KRX-0401 also modulates a number ofother key signal transduction pathways, including the JNK and MAPK pathways,which are pathways associated with programmed cell death, cell growth, celldifferentiation and cell survival. Thecompany does not use distributors or independent representatives in the UnitedStates.About LutronicLutronic is a leading developer and manufacturer of medical laser systems fordermatological and aesthetic surgery applications.
With over 160,000 users of its flagship product BillQuick around the world, theacquisition is a strong indicator of BQE`s continued growth, despite the tighteconomy. The Company is currently developing twolate-stage products: nimotuzumab, an EGFR-targeting Affinity-OptimizedAntibody(TM), and AeroLEF(R), a proprietary, inhaled-delivery composition offree and liposome-encapsulated fentanyl. He was also Senior VP and CFO with MGM Grand Hotel andCasino in Las Vegas. Although most permits would be free at first, eventuallycompanies would have to pay for or reduce their emissions,which could possibly put major emitters out of business. Pragmatic he may be, but Fayyad does not suggest his people can accommodate themselves to indefinite occupation, and the only way to end that condition is through agreement with Israel. In 2008,Rolls-Royce and its partners invested £885 million in R&D, two thirds ofwhich had the objective of further improving the environmental aspects ofits products, in particular the reduction of emissions.6.
